Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07535905 | Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients(REVIVE) | not yet recruiting | Phase 2 | 96 | University Health Network, TorontoOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT07639801 | 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors | not yet recruiting | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jun 10, 2026 |
| clinicaltrials |
| NCT07526545 | Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial(UPRISE) | not yet recruiting | N/A | 800 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07634601 | Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer | not yet recruiting | Phase 2 | 50 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07635524 | A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT. | not yet recruiting | Phase 2 | 34 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07636707 | QLF4113 in Participants With Metastatic Prostate Cancer | not yet recruiting | Phase 1 | 140 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 9, 2026 | clinicaltrials |
| NCT07623642 | A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. | not yet recruiting | Phase 2 | 227 | GV20 TherapeuticsINDUSTRY | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07631858 | Perspectives About Online Information | not yet recruiting | N/A | 3,200 | NYU Langone HealthOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07631871 | An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy | not yet recruiting | Phase 2 | 10 | Haihua YuanOTHER | 0 | Jun 8, 2026 | clinicaltrials |
| NCT07631884 | Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor | not yet recruiting | Phase 2 | 15 | Haihua YuanOTHER | 0 | Jun 8, 2026 | clinicaltrials |
| NCT07632690 | QLC5508 in Participants With Metastatic Prostate Cancer | not yet recruiting | Phase 3 | 700 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 8, 2026 | clinicaltrials |
| NCT07634094 | Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer | not yet recruiting | Phase 2 | 28 | Kalinski, Pawel, MD, PhDOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07627620 | Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer | not yet recruiting | Phase 2 | 54 | Hunan Cancer HospitalOTHER | 0 | Jun 4, 2026 | clinicaltrials |
| NCT07600515 | Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors(ANIHTA) | not yet recruiting | — | 100 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Jun 3, 2026 | clinicaltrials |
| NCT07623460 | Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer(ZENITH) | not yet recruiting | Phase 2 | 30 | Stuthi PerimbetiOTHER | 0 | Jun 3, 2026 | clinicaltrials |
| NCT07620717 | Early Diagnosis of PROstate CANcer for Black Men(PROCAN-B+) | not yet recruiting | N/A | 300 | University of SunderlandOTHER | 0 | Jun 2, 2026 | clinicaltrials |
| NCT07617818 | QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer | not yet recruiting | Phase 2 | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jun 1, 2026 | clinicaltrials |
| NCT07214506 | Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity(HOPE) | not yet recruiting | N/A | 100 | University of ArizonaOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07613567 | A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer | not yet recruiting | Phase 3 | 486 | Fujian Cancer HospitalOTHER_GOV | 1 | May 29, 2026 | clinicaltrials |
| NCT07608445 | Physiatry-Led Cancer Prehabilitation During Neoadjuvant Systemic Therapy to Improve Function in Stage III-IVA Gynecologic Cancer Patients | not yet recruiting | N/A | 25 | City of Hope Medical CenterOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07609082 | Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Ovarian Cancer Surgery(ADAPT-OC) | not yet recruiting | N/A | 36 | Jordan LeitchOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07045415 | The Effect of Pelvic Floor Muscle Exercises After Radical Prostatectomy | not yet recruiting | N/A | 10 | KTO Karatay UniversityOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07606677 | Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women | not yet recruiting | — | 1,465 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | May 26, 2026 | clinicaltrials |
| NCT07495293 | Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer | not yet recruiting | Phase 1 | 20 | Yonsei UniversityOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT07605247 | Tirzepatide in the Treatment of Endometrial Cancer(TREAT-EC) | not yet recruiting | Phase 2 | 30 | Rutgers, The State University of New JerseyOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT07583329 | Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy(V-COSMOS) | not yet recruiting | — | 160 | Cukurova UniversityOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07598032 | Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic Progression(iCCaRE) | not yet recruiting | Phase 3 | 200 | University of Ilorin Teaching HospitalOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT06298838 | High-resolution Intra-operative PSMA PET-CT in Prostate Cancer | not yet recruiting | — | 10 | IRCCS San RaffaeleOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07591623 | OCRA Distress & Unmet Needs | not yet recruiting | N/A | 250 | M.D. Anderson Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07591831 | Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer | not yet recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07592910 | A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy(MOMENT) | not yet recruiting | Phase 2 | 60 | Prostate Cancer Clinical Trials ConsortiumOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07593066 | PRIORITY Study in Cervical Cancer(PRIORITY) | not yet recruiting | — | 700 | Pontificia Universidad Catolica de ChileOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593339 | Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery | not yet recruiting | N/A | 30 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 0 | May 18, 2026 | clinicaltrials |
| NCT07593833 | Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection | not yet recruiting | — | 1,000 | Tongji HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07564102 | dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy | not yet recruiting | Phase 1 / Phase 2 | 30 | Mochida Medical USA, Inc.INDUSTRY | 1 | May 15, 2026 | clinicaltrials |
| NCT07591467 | Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer(CaBRA) | not yet recruiting | Phase 3 | 330 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07586449 | A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian Cancer(RESO) | not yet recruiting | — | 500 | Zhejiang Cancer HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07580651 | Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring((CurieInVivo)) | not yet recruiting | N/A | 20 | CISSS de Chaudière-AppalachesOTHER_GOV | 0 | May 12, 2026 | clinicaltrials |
| NCT07581288 | Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression(MIRA) | not yet recruiting | — | 50 | University of British ColumbiaOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT07577895 | Pain Comparison: Transrectal vs. Transperineal Prostate Biopsy(TRAP-PAIN) | not yet recruiting | — | 200 | Kayseri Education and Research HospitalOTHER_GOV | 1 | May 11, 2026 | clinicaltrials |
| NCT07576842 | Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV | not yet recruiting | N/A | 750 | University of California, San DiegoOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07568756 | Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation | not yet recruiting | Phase 2 | 60 | University of California, IrvineOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07571499 | Helping Young People With Testicular Cancer Using Virtual and Extended Reality(TRANSCEND-XR) | not yet recruiting | N/A | 245 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 0 | May 6, 2026 | clinicaltrials |
| NCT07568236 | A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT) | not yet recruiting | Phase 2 | 54 | Chinese University of Hong KongOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07560215 | PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort(PROMET-BR) | not yet recruiting | — | 100 | AstraZenecaINDUSTRY | 1 | May 1, 2026 | clinicaltrials |
| NCT07040501 | Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI | not yet recruiting | N/A | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07555756 | An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models | not yet recruiting | N/A | 1,080 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 2 | Apr 29, 2026 | clinicaltrials |
| NCT07541859 | Breast and Cervical Cancer Awareness Training in Visually Impaired Women(GORSEM) | not yet recruiting | N/A | 74 | Marmara UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07542704 | A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies | not yet recruiting | Phase 1 | 48 | Kumquat Biosciences Inc.INDUSTRY | 0 | Apr 21, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 10, 2026source: clinicaltrials